Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 1:24 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 961–984 of 3,553 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Fluids Clear all

Conditions: Coronary Artery Disease
Interventions: Cardiac PET, Coronary catheterization; Procedure
Lead sponsor: University of Cincinnati; Other
Eligibility: 18 Years to 100 Years
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2027
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Colo-rectal Cancer, Cancer Colon, Cancer, Rectum, Neoplasms,Colorectal, Polyps, Polyp of Colon, Adenoma, Adenoma Colon
Interventions: Not listed
Lead sponsor: Freenome Holdings Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 3,275 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 29
States / cities: Huntsville, Alabama • Chandler, Arizona • Tucson, Arizona + 25 more

Conditions: Hydrocephalus
Interventions: Endoscopic Third Ventriculostomy, CSF Shunt Insertion; Procedure
Lead sponsor: The Hospital for Sick Children; Other
Eligibility: 1 Day to 24 Months
Enrollment: 182 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2018
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Esophageal Cancer
Interventions: Liquid nitrogen spray cryotherapy with the truFreeze device; Device
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Interstitial Cystitis
Interventions: Urine stability; Other
Lead sponsor: St. Louis University; Other
Eligibility: 18 Years to 80 Years · Female only
Enrollment: 16 participants
Timeline: 2017
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Intrahepatic Cholangiocarcinoma (Icc)
Interventions: EXOMIC small RNA sequencing, EXOMIC assay (qRT-PCR validation); Diagnostic Test
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 230 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Duarte, California

Conditions: Congestive Heart Failure
Interventions: Aquadex system, IV diuretic; Device · Drug
Lead sponsor: Nuwellis, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 1
States / cities: Lombard, Illinois

Conditions: Ovarian Autotransplantation Using Cryopreserved Ovarian Tissue in Women Treated for Cancer
Interventions: Ovarian autotransplantation; Procedure
Lead sponsor: Samuel Kim, MD; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Critical Illness
Interventions: Freestyle Navigator; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2017
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Glucose Transporter Type 1 Deficiency Syndrome
Interventions: UX007; Drug
Lead sponsor: Ultragenyx Pharmaceutical Inc; Industry
Eligibility: 1 Year and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 5
States / cities: Aurora, Colorado • Miami, Florida • New York, New York + 2 more

Conditions: Smoking, Cigarette
Interventions: Standardized Research E-cigarette (SREC); Drug
Lead sponsor: Masonic Cancer Center, University of Minnesota; Other
Eligibility: 18 Years to 65 Years
Enrollment: 47 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Pleural Effusion, Cancer
Interventions: Pleuroscopy first, Thoracentesis first; Procedure
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: New York, New York

Conditions: Common Cold
Interventions: Acetaminophen 650mg+Dextromethorphan 20mg+Phenylephrine 10mg, Acetaminophen 325mg+Dextromethorphan 10mg+Phenylephrine 5mg; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 21 Years to 45 Years · Male only
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Epilepsy, Partial, Epilepsy, Localization Related
Interventions: Oxcarbazepine, Levetiracetam, Lamotrigine; Drug
Lead sponsor: Emory University; Other
Eligibility: 5 Years to 16 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 14
States / cities: Little Rock, Arkansas • San Diego, California • Aurora, Colorado + 11 more

Conditions: Hydrocephalus
Interventions: Rhaeos Shunt Monitoring System; Device
Lead sponsor: Rhaeos, Inc.; Industry
Eligibility: Not listed
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Peoria, Illinois

Conditions: Perioperative Complication
Interventions: Exercise Group, Nutrition Group; Behavioral · Dietary Supplement
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2028
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Diabetes
Interventions: Mixed Meal Test, Dual Energy X-Ray Absorptiometry (DEXA), Adipose Tissue Biopsy; Other · Procedure
Lead sponsor: AdventHealth Translational Research Institute; Other
Eligibility: 18 Years to 75 Years
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Diffuse Large B Cell Lymphoma, Post Transplant Lymphoproliferative Disorder, Primary Mediastinal (Thymic) Large B-cell Lymphoma
Interventions: DA-EPOCH-R for DLBCL, PTLD, AND PMBCL, Methotrexate, Etoposide, Doxorubicin, Vincristine, Rituximab, Cyclophosphamide, Prednisone, G-CSF; Drug
Lead sponsor: Baylor College of Medicine; Other
Eligibility: Up to 30 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Head and Neck Cancer, Patients Requiring a Free Flap Surgery
Interventions: FloTrac; Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 94 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Hydrocephalus, Normal Pressure, Hydrocephalus
Interventions: eShunt Implant; Device
Lead sponsor: CereVasc Inc; Industry
Eligibility: 65 Years to 85 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2030
U.S. locations: 11
States / cities: New Haven, Connecticut • Jacksonville, Florida • Kansas City, Kansas + 8 more

Conditions: Breast Neoplasms, Breast Cancer, Cancer of the Breast
Interventions: Docetaxel with Cytoxan, Dexamethasone; Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2015
U.S. locations: 3
States / cities: Atlanta, Georgia

Conditions: Metastatic NSCLC
Interventions: GME751, Keytruda-EU; Drug
Lead sponsor: Sandoz; Industry
Eligibility: 18 Years and older
Enrollment: 218 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Fountain Valley, California

Conditions: Shock
Interventions: Ascorbic Acid, Ringers Lactate or Normal Saline; Drug · Other
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Smoking, Tobacco Use
Interventions: Electronic Cigarette; Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 21 Years and older
Enrollment: 638 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Charleston, South Carolina

Search by objective public record fields.

Improvement Assessment of Coronary Flow Dysfunction Using Fundamental Fluid Dynamics

AI-EMERGE: Development and Validation of a Multi-analyte, Blood-based Colorectal Cancer Screening Test

A Study Comparing Two Treatments for Infants With Hydrocephalus

Spray Cryotherapy for Esophageal Cancer (ICE-CANCER)

Platelet Activating Factor Stability in Urine

Liquid Biopsy Using Exosomal miRNA Enables Risk Stratification of Potential Metastasis in Patients With Intrahepatic Cholangiocarcinoma.

Ultrafiltration Versus Intravenous (IV) Diuretics for Patients Hospitalized for Acute Decompensated Heart Failure: (UNLOAD)

Human Ovarian Autotransplantation

Continuous Glucose Monitoring With a Subcutaneous Sensor During Critical Illness and Surgery

Study to Assess the Long Term Safety and Efficacy of UX007 in Participants With Glucose Type 1 Deficiency Syndrome (Glut1 DS)

Biomarkers of Exposure and Effect in Standardized Research E-cigarette (SREC) Users

Pleuroscopy First Versus Thoracentesis First in Patients With Suspected Malignant Pleural Effusions

To Investigate the Gastrointestinal Behaviour of Two Triple Combination Products in Healthy Male Volunteers

Cognitive AED Outcomes in Pediatric Localization Related Epilepsy (COPE)

Flow Detection in Open and Closed Shunt Valve Periods

Exercise in Patients Undergoing Urologic Surgery

CharacterIzation of Adult Onset Autoimmune Diabetes

Dose Adjusted EPOCH-R, to Treat Mature B Cell Malignancies

A Prospective Study Evaluating the Use of Intraoperative Stroke Volume Variation Via the FloTrac Device to Guide Fluid and Vasopressor Management in Head and Neck Free Flaps

US Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus

Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence Scores

A Study to Compare Efficacy, Safety, and Immunogenicity of GME751 and EU-authorized Keytruda in Adult Participants With Untreated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC)

High Dose Vitamin C in the Critically Ill Patient

Clinical Outcomes of a Nationwide, Naturalistic E-Cig Trial (CONNECT)